• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16732 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     Quality Improvement Scotland (NHS QIS ) Screening tools, detoxification and vitamin supplementation for alcohol dependence
2007     HAYES, Inc. Total ankle replacement
2007     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of knowledge on the Coughassist (TM) (from Emerson), a mechanical system for clearance of bronchial secretions
2007     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Description of the current status of the prenatal screening of the most frequent fetal chromosomal diseases -especially Down's Syndrome- in Spain, and proposals for improvement of everyday clinical practice
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dexrazoxane (Savene®)
2007     Quality Improvement Scotland (NHS QIS ) Cardiac resynchronisation therapy for the treatment of heart failure
2007     HAYES, Inc. Transurethral microwave thermotherapy
2007     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Development of the methodology and pilot implementation of prosthetic implant registers in the National Health system
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Clofarabine (Evoltra®)
2007     Andalusian Health Technology Assessment Area (AETSA) Guide for decision-making on the introduction of new genetic tests in the National Health System (GEN Guide)
2007     Quality Improvement Scotland (NHS QIS ) Carmustine implants and temozolomide for the treatment of newly diagnosed high grade glioma
2007     HAYES, Inc. Ultrasound-enhanced transcutaneous drug delivery
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine (Emtriva®)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for the acquisition of new technologies
2007     Quality Improvement Scotland (NHS QIS ) Alteplase for the treatment of acute ischaemic stroke
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic performance and costeffectiveness of technologies to measure bone mineral density in postmenopausal women
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/tenofovir DF (Truvada®)
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guidance for the introduction of new drugs
2007     Quality Improvement Scotland (NHS QIS ) Varenicline for smoking cessation
2007     NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (CNTO-148) for ankylosing spondylitis
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Parathyroid hormone (PTH) (Preotact®)
2007     Quality Improvement Scotland (NHS QIS ) Adalimumab for the treatment of psoriatic arthritis
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales
2007     Andalusian Health Technology Assessment Area (AETSA) [Update of the guide for the introduction of new drugs (GINF)]
2007     Quality Improvement Scotland (NHS QIS ) Rituximab for the treatment of rheumatoid arthritis
2007     HAYES, Inc. Robotically assisted atrial septal defect repair (da Vinci Surgical System) (Intuitive Surgical Inc.)
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of alglucosidase alfa (Myozyme™) within NHS Wales
2007     Quality Improvement Scotland (NHS QIS ) Natalizumab for the treatment of adults with highly active relapsing-remitting multiple sclerosis
2007     HAYES, Inc. Dermoscopy for detection of melanoma
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sodium phenylbutyrate within NHS Wales
2007     Andalusian Health Technology Assessment Area (AETSA) Intraperitoneal chemotherapy in advanced epithelial ovarian cancer
2007     Quality Improvement Scotland (NHS QIS ) Bortezomib monotherapy for relapsed multiple myeloma
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Laronidase (Aldurazyme®)
2007     Andalusian Health Technology Assessment Area (AETSA) Clinical applications of proteomic techniques
2007     HAYES, Inc. Robotically assisted mitral valve repair (da Vinci Surgical System) (Intuitive Surgical Inc.)
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Enfuvirtide
2007     Andalusian Health Technology Assessment Area (AETSA) Positron Emission Tomography combined with Magnetic Resonance (PET/RM)
2007     HAYES, Inc. DISC nucleoplasty (ArthroCare Perc-D SpineWand) for percutaneous disc decompression
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Anagrelide (Xagrid®)
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of iloprost trometamol (Ventavis®) within NHS Wales
2007     NIHR Horizon Scanning Centre (NIHR HSC) Xaliproden (Xalprila) for Alzheimer's disease: horizon scanning technology briefing
2007     HAYES, Inc. Selective laser trabeculoplasty (SLT) using the Selecta 7000 (Lumenis Inc.) for treatment of primary open-angle glaucoma and ocular hypertension
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for heart failure (NYHA): horizon scanning technology briefing
2007     VA Technology Assessment Program (VATAP) A summary of the evidence for use of acupuncture from systematic reviews and meta-analyses
2007     HAYES, Inc. Dynesys dynamic stabilization system (Zimmer Inc.) for degenerative spondylolisthesis
2007     WorkSafeBC Musculoskeletal disorders of the upper extremities. Are they associated with computer work?
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir disoproxil fumarate for hepatitis B: horizon scanning technology briefing
2007     NIHR Horizon Scanning Centre (NIHR HSC) Temozolomide (Temodal) for advanced metastatic melanoma: horizon scanning technology briefing
2007     Agency for Healthcare Research and Quality (AHRQ) Use of aspirin and NSAIDs to prevent colorectal cancer; an evidence synthesis
2007     HAYES, Inc. Electrical stimulation of the occipital nerve for the treatment of occipital neuralgia
2007     Adelaide Health Technology Assessment (AHTA) Home studies for the diagnosis of sleep disorders
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tap water home haemodialysis systems for end stage renal failure: horizon scanning technology briefing
2007     Agency for Healthcare Research and Quality (AHRQ) Screening for lipid disorders in children and adolescents:systematic evidence review for the U.S. Preventive Services Task Force
2007     Adelaide Health Technology Assessment (AHTA) Microvolt T-wave alternans for the determination of patients likely to benefit from ICD therapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma: horizon scanning technology briefing
2007     Agency for Healthcare Research and Quality (AHRQ) Screening for hemoglobinopathies in newborns: reaffirmation update for the U.S. Preventive Services Task Force
2007     Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis
2007     Adelaide Health Technology Assessment (AHTA) Genetic screening for familial hypercholesterolaemia
2007     NIHR Horizon Scanning Centre (NIHR HSC) Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2007     Agency for Healthcare Research and Quality (AHRQ) Updating systematic reviews
2007     Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computed tomography
2007     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Bay 59-7939) for the prevention of venous thromboembolism (VTE) after major orthopaedic surgery: horizon scanning technology briefing
2007     HAYES, Inc. Endoscopic strip craniectomy with cranial helmet molding for primary craniosynostosis
2007     Adelaide Health Technology Assessment (AHTA) Electrochemotherapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Prasugrel for acute coronary artery syndrome with percutaneous coronary intervention: horizon scanning technology briefing
2007     HAYES, Inc. Spinal manipulation under anesthesia for the treatment of pain
2007     Adelaide Health Technology Assessment (AHTA) MRI for the detection of foetal abnormalities
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral topotecan (Hycamtin) for small cell lung cancer: horizon scanning technology briefing
2007     HAYES, Inc. Erythropoiesis-stimulating agents (ESAs) for interferon/ribavirin-induced anemia in HIV-negative patients with hepatitis C
2007     Adelaide Health Technology Assessment (AHTA) Activecare DVT® for the prevention of deep vein thrombosis
2007     NIHR Horizon Scanning Centre (NIHR HSC) On-line haemodialfiltration for end stage renal failure: horizon scanning technology briefing
2007     HAYES, Inc. ExAblate 2000 system (InSightec Ltd.) for ablation of uterine fibroids
2007     Adelaide Health Technology Assessment (AHTA) Rapid transcranial magnetic stimulation for stroke rehabilitation
2007     NIHR Horizon Scanning Centre (NIHR HSC) Myocardial stress perfusion magnetic resonance imaging (MRI) assessment of myocardial blood flow in coronary artery disease: horizon scanning technology briefing
2006     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness and safety of analgesics for osteoarthritis
2006     Quality Improvement Scotland (NHS QIS ) Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
2006     Adelaide Health Technology Assessment (AHTA) Niobe® magnetic guidance system for coronary interventions
2006     Medical Advisory Secretariat (MAS) Enhanced external counterpulsation (EECP): an evidence-based analysis
2006     Quality Improvement Scotland (NHS QIS ) Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer
2006     HAYES, Inc. Facial muscle, sinus, and trigeminal nerve surgery for migraine headaches
2006     HAYES, Inc. Temporomandibular joint (TMJ) reconstruction with the patient-fitted TMJ reconstruction prosthesis (TMJ Concepts)
2006     Adelaide Health Technology Assessment (AHTA) Breath test for the detection of lung cancer in high-risk patients
2006     Quality Improvement Scotland (NHS QIS ) HEPA cabinets to dry and store flexible endoscopes
2006     HAYES, Inc. Femoral head resurfacing arthroplasty for the treatment of osteonecrosis
2006     Adelaide Health Technology Assessment (AHTA) ZstatFlu® point-of-care influenza test
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Management of chronic (non-cancer) pain: organization of health services
2006     Medical Services Advisory Committee (MSAC) Brachytherapy for the treatment of prostate cancer: assessment report May 2005
2006     HAYES, Inc. Fluorescent in situ hybridization (FISH) for prenatal detection of genetic abnormalities
2006     Belgian Health Care Knowledge Centre (KCE) Capsule endoscopy
2006     HAYES, Inc. Totally extraperitoneal (TEP) laparoscopic surgery for treatment of athletic pubalgia
2006     NIHR Health Technology Assessment programme An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial
2006     HAYES, Inc. Genetic testing for thiopurine s-methyltransferase (TPMT) activity for prediction of response to thiopurine drug therapy for inflammatory bowel disease
2006     NIHR Health Technology Assessment programme Accurate, practical and cost-effective assessment of carotid stenosis in the UK
2006     NIHR Health Technology Assessment programme Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2006     HAYES, Inc. Helical tomotherapy (TomoTherapy Hi-Art System) for non-small cell lung cancer (NSCLC)
2006     NIHR Health Technology Assessment programme The cost-effectiveness of testing for hepatitis C in former injecting drug users
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Strategies to reduce emergency department overcrowding
2006     NIHR Health Technology Assessment programme Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial)
2006     HAYES, Inc. Vertical expandable prosthetic titanium rib (VEPTR) (Synthes Inc.) for thoracic insufficiency syndrome